Suppr超能文献

比较使用电子健康记录的动态治疗策略的效果:参数 g 公式在贫血管理策略中的应用。

Comparing the Effectiveness of Dynamic Treatment Strategies Using Electronic Health Records: An Application of the Parametric g-Formula to Anemia Management Strategies.

机构信息

Medical Technology and Practice Patterns Institute, Bethesda, MD.

Department of Population Medicine, Harvard Medical School, Boston, MA.

出版信息

Health Serv Res. 2018 Jun;53(3):1900-1918. doi: 10.1111/1475-6773.12718. Epub 2017 May 30.

Abstract

OBJECTIVE

To compare the effectiveness of dynamic anemia management strategies by applying the parametric g-formula to electronic health records.

DATA SOURCE/STUDY SETTING: Patients with end-stage renal disease from the US Renal Data System who had congestive heart failure or ischemic heart disease and were undergoing hemodialysis in outpatient dialysis facilities between 2006 and 2010.

STUDY DESIGN

We explicitly emulated a target trial of three ‎erythropoietin dosing strategies (aimed at achieving a low, middle, or high hematocrit) and estimated the observational analog of the per-protocol effect.

RESULTS

Of 156,945 eligible patients, 41,970 died during the 18-month follow-up. Compared to the low-hematocrit strategy, the estimated risk of death was 4.6 (95% CI 4.4-4.9) percentage points higher under the high-hematocrit strategy and 1.8 (95% CI 1.7-1.9) percentage points higher under the mid-hematocrit strategy. The corresponding risk differences for a composite outcome of death and myocardial infarction were similar.

CONCLUSION

An explicit emulation of a target trial using electronic health records, combined with the parametric g-formula, allowed comparison of real-world dynamic strategies that have not been compared in randomized trials.

摘要

目的

通过应用参数 g 公式对电子健康记录进行分析,比较动态贫血管理策略的效果。

数据来源/研究范围:2006 年至 2010 年间,在美国肾脏数据系统中患有充血性心力衰竭或缺血性心脏病且正在接受门诊透析设施血液透析的终末期肾病患者。

研究设计

我们明确模拟了三种促红细胞生成素给药策略的目标试验(旨在实现低、中或高血细胞比容),并估计了观察性协议效果的模拟。

结果

在 156945 名符合条件的患者中,有 41970 人在 18 个月的随访期间死亡。与低血细胞比容策略相比,高血细胞比容策略下的死亡风险估计高出 4.6(95%CI 4.4-4.9)个百分点,中血细胞比容策略下的死亡风险估计高出 1.8(95%CI 1.7-1.9)个百分点。死亡和心肌梗死复合结局的相应风险差异也相似。

结论

使用电子健康记录进行明确的目标试验模拟,并结合参数 g 公式,允许比较尚未在随机试验中比较的真实世界动态策略。

相似文献

4
The normal hematocrit study--follow-up.正常血细胞比容研究——随访
N Engl J Med. 2008 Jan 24;358(4):433-4. doi: 10.1056/NEJMc076523.

引用本文的文献

8
Randomized controlled trials of biomarker targets.随机对照试验的生物标志物靶点。
Clin Trials. 2023 Feb;20(1):47-58. doi: 10.1177/17407745221131820. Epub 2022 Nov 14.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验